Longitudinal T cell responses to a series of four SARS-CoV-2 vaccine doses in patients on TNF inhibitors

被引：0

作者：

Orbo, H. ^{[1
,2
]}

Wolf, A. ^{[3
]}

Bjorlykke, K. ^{[2
,4
]}

Josefsson, S. ^{[3
]}

Solum, G. ^{[3
]}

Kjonstad, I. ^{[3
]}

Jyssum, I. ^{[1
,2
]}

Christensen, I. ^{[1
,2
]}

Tveter, A. ^{[1
]}

Sexton, J. ^{[1
]}

Kro, G. ^{[5
]}

Grodeland, G. ^{[2
,6
]}

Kvien, T. ^{[1
,2
]}

Jahnsen, J. ^{[4
]}

Vaage, J. ^{[6
]}

Haavardsholm, E. ^{[1
,2
]}

Provan, S. ^{[1
]}

Kared, H. ^{[6
,7
]}

Munthe, L. ^{[2
,6
,7
]}

Jorgensen, K. ^{[4
]}

Syversen, S. ^{[1
]}

Mjaaland, S. ^{[3
]}

Goll, G. ^{[1
]}

机构：

[1] Diakonhjemmet Hosp, Ctr Treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway

[2] Univ Oslo UiO, Inst Clin Med, Oslo, Norway

[3] Norwegian Inst Publ Hlth, Dept Method Developement & Analyt, Oslo, Norway

[4] Akershus Univ Hosp, Dept Gastroenterol, Nordbyhagen, Norway

[5] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway

[6] Oslo Univ Hosp, Dept Immunol, Oslo, Norway

[7] Univ Oslo UiO, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway

来源：

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2023年 / 52卷

关键词：

COVID-19; vaccination; adaptive immunity;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PP44

引用

页码：103 / 104

页数：2

共 50 条

[41] Defending against SARS-CoV-2: The T cell perspective
Almendro-Vazquez, Patricia
Laguna-Goya, Rocio
Paz-Artal, Estela
FRONTIERS IN IMMUNOLOGY, 2023, 14
[42] Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy
Pontrelli, Giuseppe
Cimini, Giulio
Roversi, Marco
Gabrielli, Andrea
Salina, Gaetano
Bernardi, Stefania
Rocchi, Francesca
Simonetti, Alessandra
Giaquinto, Carlo
Rossi, Paolo
Labini, Francesco Sylos
FRONTIERS IN PUBLIC HEALTH, 2021, 9
[43] Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses
Hill, Edward M.
Keeling, Matt J.
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2021, 18 (182)
[44] SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients
Basic-Jukic, Nikolina
Ivo, Jelicic
TRANSPLANT INFECTIOUS DISEASE, 2021,
[45] Lack of Specific Immune Response after Five Doses of mRNA SARS-CoV-2 Vaccine in a Patient with CD4+ T-Cell Lymphopenia but Preserved Responses to CMV
Alba-Cano, Trinidad
Fernandez-Cruz, Eduardo
Alonso, Roberto
Munoz-Gomez, Sara
de Diego, Rebeca Perez
Martinez, Elena Garcia
Sanchez-Mateos, Paloma
Caspistegui, Joaquin Navarro
Lopez, Monica Martin
Gil-Herrera, Juana
VACCINES, 2024, 12 (04)
[46] Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?
Murt, Ahmet
Altiparmak, Mehmet Riza
Yadigar, Serap
Yalin, Serkan Feyyaz
Ozbey, Dogukan
Yildiz, Zeynep
Kocazeybek, Bekir
Pekpak, Meltem
Ataman, Muveddet Rezzan
THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (04) : 769 - 774
[47] Hematuria in patients with IgA nephropathy after vaccine for SARS-CoV-2
Garcia, Leonardo Calle
Varas, Carmen Martin
Rodriguez, Giomar Urzola
Hidalgo, Maria Marcos
Gomez, Astrid Rodriguez
Ordas, Alvaro Molina
Gonzalez, Veronica Fidalgo
Garrote, Pablo Sanchez
Gutierrez, Paulo Garcia
de Burgos, Marta Garcia
Luis, Maria Jose Fernandez-Reyes
NEFROLOGIA, 2023, 43 (05): : 657 - 659
[48] Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study
Ladeira, Filipa
Nobrega, Claudia
Cerqueira, Joao
COVACiMS Collaborators, Carlos
JOURNAL OF NEUROLOGY, 2025, 272 (04)
[49] Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
Weintraub, Michael A.
Ameer, Barbara
Gregory, Naina Sinha
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2021, 9
[50] Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need
Cheng, Yi-Ling
Chang, Shen-Shin
Chao, Chiao-Hsuan
Chen, Po-Ta
Lin, Ya-Lan
Syu, Guan-Da
Lee, Nan-Yao
Chen, Po-Lin
Ko, Wen-Chien
Ho, Tzong-Shiann
MICROBIOLOGY SPECTRUM, 2024, 12 (06):

← 1 2 3 4 5 →